Tue, February 17, 2009
Mon, February 16, 2009
Fri, February 13, 2009
Thu, February 12, 2009
Wed, February 11, 2009
Tue, February 10, 2009
Mon, February 9, 2009
Sun, February 8, 2009
Fri, February 6, 2009
Thu, February 5, 2009
Wed, February 4, 2009
Tue, February 3, 2009
Mon, February 2, 2009

Gilead Sciences to Present at the 11th Annual BIO CEO Investor Conference on Tuesday, February 10


//health-fitness.news-articles.net/content/2009/ .. -investor-conference-on-tuesday-february-10.html
Published in Health and Fitness on Friday, February 6th 2009 at 13:28 GMT, Last Modified on 2009-02-06 13:29:27 by Market Wire   Print publication without navigation


FOSTER CITY, Calif.--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate presentation will be webcast from the 11th Annual BIO CEO Investor Conference in New York.

John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company on Tuesday, February 10 at noon Eastern Time.

To access the live webcast via the internet log on to [ www.gilead.com ]. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit [ www.gilead.com ] or
call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).


Publication Contributing Sources